Airway Progenitor Cell Proliferation and Differentiation during Lung Repair This application responds to RFA-HL-12-006 to participate in a Consortium for the study of "Lung Repair and Regeneration." The proposal seeks to establish a participating Center working closely with other national "Consortium" members. Our proposed Center consists of faculty led by Dr. Jeffrey Whitsett at Cincinnati Children's Hospital IVIedical Center (CCHMC) and Dr. Philip Streeter at the Oregon Health and Science University (OHSU), who have established collaborations for the study of lung biology. Our Center provides four specific aims, all focused to transcriptional mechanisms controlling proliferation and differentiation of Airway Epithelial Cell (AEC) progenitors.
The Aims also generate and provide new antibodies, gene expression data and transgenic models of broad application to the field of Pulmonary Biology and Medicine.
Aim 1 will elucidate the role of a novel transcriptional network controlling AEC progenitors and their differentiation in conducting airways, with focus to the role of a PAX9-centered transcriptional network in the regulation of basal cell proliferation and differentiation.
Aim 2 will produce, characterize and use monoclonal and polyclonal antibodies for the identification and purification of human and mouse AECs for study of lung repair and disease.
Aim 3 will define gene expression patterns and transcriptional regulators critical for AEC homeostasis with focus to PAX9 and associated factors.
This Aim will create and standardize expression and transcriptional databases for human and mouse AECs and iPS cells induced to specific airway cell lineages.
Aim 4 will produce novel transgenic mice for the conditional deletion and addition of genes in conducting AECs, including those related to the study of PAX9. Preliminary data accompanying this application were produced via close collaborations and interactions between members of laboratories in multiple divisions at CCHMC in the fields of Pulmonary Biology, Developmental Biology, Hematology/Oncology, and Bioinformatics, as well as those at OHSU and the Oregon Stem Cell Center. Our investigators have long-standing commitments and success related to the building and sharing of useful technologies and reagents and have been long committed to training others to advance the field of pulmonary biology and medicine.
This U01 grant seeks to provide (1) novel insights into the molecular and cellular control of AEC progenitors and their differentiation and (2) novel reagents, tools and procedures enabling scientific advancements of value to the field of pulmonary medicine.
|Chen, Gang; Korfhagen, Thomas R; Karp, Christopher L et al. (2014) Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity. Am J Respir Crit Care Med 189:301-13|
|Bridges, James P; Schehr, Angelica; Wang, Yanhua et al. (2014) Epithelial SCAP/INSIG/SREBP signaling regulates multiple biological processes during perinatal lung maturation. PLoS One 9:e91376|
|Whitsett, Jeffrey A (2014) The molecular era of surfactant biology. Neonatology 105:337-43|
|Hogan, Brigid L M; Barkauskas, Christina E; Chapman, Harold A et al. (2014) Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell 15:123-38|
|Lange, Alexander W; Haitchi, Hans Michael; LeCras, Timothy D et al. (2014) Sox17 is required for normal pulmonary vascular morphogenesis. Dev Biol 387:109-20|
|Wan, Huajing; Liu, Caijun; Wert, Susan E et al. (2013) CDC42 is required for structural patterning of the lung during development. Dev Biol 374:46-57|
|Cornett, Bridget; Snowball, John; Varisco, Brian M et al. (2013) Wntless is required for peripheral lung differentiation and pulmonary vascular development. Dev Biol 379:38-52|
|Ren, Xiaomeng; Shah, Tushar A; Ustiyan, Vladimir et al. (2013) FOXM1 promotes allergen-induced goblet cell metaplasia and pulmonary inflammation. Mol Cell Biol 33:371-86|
|Hao, Huifang; Maeda, Yutaka; Fukazawa, Takuya et al. (2013) Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer. PLoS One 8:e71093|
|Bell, Sheila M; Zhang, Liqian; Xu, Yan et al. (2013) Kruppel-like factor 5 controls villus formation and initiation of cytodifferentiation in the embryonic intestinal epithelium. Dev Biol 375:128-39|